<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Anders Vikstrom | Ruth Palmer Lab</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/anders-vikstrom/</link><atom:link href="https://deploy-preview-3--ruthpalmerlab.netlify.app/author/anders-vikstrom/index.xml" rel="self" type="application/rss+xml"/><description>Anders Vikstrom</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Tue, 09 Jan 2024 00:00:00 +0000</lastBuildDate><image><url>https://deploy-preview-3--ruthpalmerlab.netlify.app/media/icon_hua1ac8766117554d27209418f2eeeba33_52656_512x512_fill_lanczos_center_3.png</url><title>Anders Vikstrom</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/anders-vikstrom/</link></image><item><title>ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/alk_f1174s/</link><pubDate>Tue, 09 Jan 2024 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/alk_f1174s/</guid><description/></item></channel></rss>